Bernard A. Fox

OSI SAF Sea Ice Concentration ICDR from AMSR-2 (OSI-438) for the 18/06/2025 - Northern Hemisphere

OSI SAF Sea Ice Concentration ICDR from AMSR-2 (OSI-438) for the 18/06/2025 - Southern Hemisphere

🛰️New Product ! 🛰️
Our #SeaIce team at @met.no and @dmidk.bsky.social
has been working hard to ensure you reliable and lasting access to sea ice concentration Climate Data Record.
Today we release as demonstrational a new #AMSR-2 based Interim CDR (OSI-438)

osi-saf.eumetsat.int/community/li...

So very sad.

#SITC25 Science Preview: Join @bernardafox.bsky.social,
@klebanofflab.bsky.social, Rom S. Leidner, MD, Earle A. Chiles Research Institute, Catherine J. Wu, MD
@danafarber.bsky.social to describe novel cancer antigens derived from the dark genome. Browse details: www.sitcancer.org/2025/schedul...

Prof. Richard Wahl redefines #Theranostics & shows how #PET can be used to identify response and prevent over-treatment #Malinckodt #Institute of #Radiology #FinishCancer #ASTRO2025

More #THERANOSTICS -
Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social

#Theranostics can cure some patients? Here is an example of a patient with metastatic #ThyroidCancer that has long-term disease-free survival / @mskcancercenter.bsky.social #ASTRO2025 #FinishCancer

THERANOSTICS

WHAT IS IT? Answer below..
Why should you care?? It is improving outcomes for men with #prostate #cancer - #Pluvicto
#Bayer #Novartis #FinishCancer #ASTRO2025 #PCF @prostatecanceruk.bsky.social @ipcr.bsky.social @ip-london.bsky.social #CRUK @cruk-mi.bsky.social @prostates.bsky.social

🧐???? #THERANOSTICS ????

Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social
#cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer

💥#TIMO2025 Great line-up of #immunotherapy experts/I talked #Cancer #antigens & #DarkGenome-derived #DarkMatter/ IMO: Recent studies explain why combination #immunotherapy with #personalized #neoantigen #vaccines are SUBOPTIMAL. See www.nature.com/articles/s43... www.science.org/doi/10.1126/...

Dr. Tyler Hulett from #CDI #puertoRico is wowing the crowd at #AAI2025 with methods to assay antibody responses in serum! They are making progress advancing the field with everything from Ab to IG isotypes to considering #DarkGenome protein arrays! #cancer #immunotherapy #seromics

Deaths from heart disease down 75%, that’s NIH.

Deaths from stroke down 75%, that’s NIH.

HIV/AIDS no longer a death sentence, that’s NIH.

99% of FDA approved drugs in the last decade, that’s NIH.

Please show this video to anyone who doesn’t understand why the NIH is so important.

💥🦊🎶 WORK HARD/PLAY HARD! Today at #AACR2025 was closed out by #checkpoints closing song, “Don’t Stop Believin” /it resonates with me - not only because I was born & raised in #Detroit (& NW suburbs) but because songs message - Believin we can #cure #cancer @sitcancer.bsky.social #FinishCancer

A pipeline for inferring reproducible tumour microenvironment ecosystems from scRNA-seq atlases

Interested in how to infer tumour microenvironment ecosystems from scRNA-seq atlases?

I'll be at #AACR25 presenting in the ED06 session this Friday 3-4.30pm.

Otherwise would love to meet to chat science for anyone on here attending

Preprint: www.biorxiv.org/content/10.1...

Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer

💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer

Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI

a map of Canada showing where measles is most and least active

Measles is spreading across Canada, with 470 cases in Ontario. A look at the affected areas globalnews.ca/news/1108874... @kdangerfield.bsky.social

𝗚𝗲𝘁 𝘄𝗲𝗲𝗸𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀: CanadaHealthwatch.ca/newsletter 🍁

This is insane

This is more important than you realize. Bluesky doesn’t downgrade links. Which means news sites will get more traffic from here than other sites.

Which gives them economic reasons to post here first.

YouTube video by Johns Hopkins Bloomberg School of Public Health Research Saves Lives. #shorts

Research Saves Lives.

Here at the Johns Hopkins Bloomberg School of Public Health research is about more than just data-it's about people.

Every future discovery starts with the work happening now. Read more about our research: hub.jhu.edu/research-sav...

youtube.com/shorts/q90oY...

Come join us in Salem to #StandUpForScience !! 🧪

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer - Nature In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited marked lo...

Promising results from @MSKCancerCenter and collaborators

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer

www.nature.com/articles/s41...

Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1 - Nature Reviews Immunology In this Perspective, Honjo and co-workers describe the discovery of PD1 and its journey to become a major target for cancer immunotherapy. It discusses the complex regulatory systems that govern PD1 e...

"Insights from a 30-year journey: function, regulation & therapeutic modulation of PD1"
Fm @natrevimmunol.bsky.social 2023: a history of the development of #antiPD1 #immunotherapy by Honjo, Chamoto et al.
#Immunology #Immunosky
www.nature.com/articles/s41...

Bernard A. Fox: UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter - OncoDaily Bernard A. Fox: UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter / Alan Braynin, Alan Korman, Asthika Goonewardene,

Appreciate @oncodaily publishing LinkedIn post highlighting world’s 1st cancer’s #DarkMatter #immunotherapy! This strategy has tripled response rates! www.einpresswire.com/article/7584... @UbiVac looking to move this off-the-shelf drug to other #cancers @ChilesResearch

oncodaily.com/blog/232771

Wafik, thank you! For sharing!

Every week, I check the CDC's Mortality and Morbidity Weekly Report. This week for the first time in its 60 years it was not published on schedule. American healthcare workers all over the country are less informed about health crises that affect their patients. CDC led reports matter a 🧵

“We must accept finite disappointment, but never lose infinite hope.”
- Dr. Martin Luther King

Listen up.

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDA

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

www.businesswire.com/news/home/20...

The cover image portrays a human composed of proteins who is examining their health status (represented by the ECG monitoring interface) with the assistance of artificial intelligence (represented by the chip and binary codes).

Something you don't see every day!
Digitizing the human proteome in >53,000 individuals with 15-year follow-up and, with machine learning, unraveling nearly 500 disease-causing proteins
www.cell.com/cell/fulltex...
open-access